Not Yet RecruitingNCT06904092
Official study titleEfficacy and Mechanisms of Transcranial Ultrasound Stimulation (TUS) on Cognitive Deficits in Schizophrenia:Based on the Hippocampal-Prefrontal Circuit
This study isn't recruiting yet.
In ShanghaiSchizophreniaDevice studyAges 18–50
- Countries
- China
- Sponsor
- Shanghai Mental Health Center
Not Yet RecruitingNCT07401784
This study isn't recruiting yet.
Remote / onlineAnxiety, DepressionDevice studyAges 18–80
- Countries
- Sponsor
- Second Affiliated Hospital of Nanchang University
Not Yet RecruitingNCT07529574
What is this study about?This study evaluates the safety and effectiveness of transcranial magnetic stimulation for people with depression.
This study isn't recruiting yet.
In SeoulDepressionMedication studyAges 15+
- Countries
- South Korea
- Sponsor
- Jung-Sun Lee
Not Yet RecruitingNCT07369713
Official study titleEfficacy and Safety of Accelerated Intermittent Theta-burst Stimulation (a-iTBS) in Adolescents With Depressive Disorder: A Randomized, Double-Blind, Controlled Pilot Study
This study isn't recruiting yet.
In ChongqingDepressionDevice studyAges 12–18
- Countries
- China
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
Not Yet RecruitingNCT02129751
What is this study about?Researchers are comparing bupropion hydrobromide and placebo, tracking side effects to assess safety in children and adolescents with depression.
This study isn't recruiting yet.
Location not clearly listedDepressionMedication studyAges 7–17
- Countries
- Sponsor
- Bausch Health Americas, Inc.
Not Yet RecruitingNCT07555743
What is this study about?Researchers are comparing Daridorexant 50 mg and placebo to find out how the approaches affect sleep difficulties in people with depression.
This study isn't recruiting yet.
In BarcelonaDepressionMedication studyAges 18–99
- Countries
- Spain
- Sponsor
- Institut d'Investigació Biomèdica de Bellvitge
Not Yet RecruitingACTRN12625000799459
Official study titleFIFO-PAT-20: A sequential multiple assignment randomised controlled trial comparing the efficacy and safety of treatment as usual against a Fly-In-Fly-Out (FIFO) model of Psilocybin-Assisted Therapy (PAT) for Major Depressive Disorder (MDD), alongside randomised adjunctive support (virtual-reality vs journalling)
This study isn't recruiting yet.
In AustraliaDepressionInterventional studyAges 18–75
- Countries
- Australia
- Sponsor
- Monash University
Not Yet RecruitingACTRN12623000803695
Official study titleEfficacy and Safety of Low-dose Cannabidiol for anxiety in adults: A randomised, double-blind placebo-controlled study
This study isn't recruiting yet.
In BrisbaneAnxietyInterventional studyAges 18–70
- Countries
- Australia
- Sponsor
- PharmaCann Pty Ltd
Not Yet RecruitingNCT06443242
Official study titleEfficacy and Safety of Low-dose Laser Acupuncture on Treating Insomnia Associated With Major Depressive Disorder: A Randomised Controlled Trial
This study isn't recruiting yet.
Location not clearly listedDepressionDevice studyAges 18–60
- Countries
- Sponsor
- Mohammad Farris Iman Leong Bin Abdullah
Not Yet RecruitingNCT07153835
Official study titleEvaluation of Efficacy and Safety of Paliperidone Among People With Schizophrenia in Bangladesh
This study isn't recruiting yet.
In BarishalSchizophreniaMedication studyAges 18–60
- Countries
- Bangladesh
- Sponsor
- Sher-E-Bangla Medical College
Not Yet RecruitingNCT07185464
Official study titleEfficacy and Safety of Transcranial Alternating Current Stimulation (tACS) in Adolescents With First-episode Depression Who Are Drug-naive: A Randomized, Double-blind, Controlled Pilot Study
This study isn't recruiting yet.
In ChongqingDepressionDevice studyAges 12–18
- Countries
- China
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
Not Yet RecruitingNCT07612501
Official study titleEfficacy and Safety of Transcranial Temporal Interference Stimulation for Depression
This study isn't recruiting yet.
In NanjingDepressionDevice studyAges 18–65
- Countries
- China
- Sponsor
- Yonggui Yuan